Clinician handoff
Chemobrain
Designed for a 60-second scan in primary care. Use this to explain why this theory fits, what would weaken it, and which tests are most worth discussing.
Why this still fits
I want to evaluate whether my cognitive symptoms fit treatment-related chemobrain and what overlapping factors like sleep, anemia, pain, or medication effects still need to be ruled out.
What would weaken it
- -No treatment timeline linking the cognitive change to chemotherapy, radiation, hormonal therapy, or cancer treatment stress.
- -A stronger explanation from anemia, sleep disruption, depression, meds, or another overlap around treatment.
- -The fog predates treatment or behaves in a way that doesn't track with the cancer timeline at all.
Key points to communicate
- •I want to know whether this is treatment-related cognitive injury versus a treatable overlap from the same period.
- •Please separate chemobrain from anemia, thyroid issues, sleep loss, pain, and medication burden.
- •If this is chemobrain, I want realistic expectations and the next steps that actually help.
Bring this to the visit
- •Cancer treatment history: chemotherapy agents, radiation fields, surgery dates, hormone therapy.
- •A timeline of when cognitive symptoms started relative to treatment.
- •Any prior neuropsychological testing or cognitive screening results.
- •Current medications including hormone blockers, pain medications, and sleep aids.
Useful screening structure
- -MoCA or FACT-Cog (Functional Assessment of Cancer Therapy - Cognitive Function).
- -PHQ-9 for depression screening - very common post-treatment and overlaps with chemo fog.
- -Sleep quality assessment since cancer-related insomnia drives fog independently.
Tests and measurements to discuss
Medication Review
What this helps clarify: Medication-related brain fog is often missed because nobody lays the full timeline out in one place.
Range context
Structured medication timeline + risk review
How to use the result
Ask whether a pharmacist-led medication therapy management review is available.
Neuropsychological Testing
CBC + CMP
What this helps clarify: Baseline panel combining complete blood count and metabolic chemistry for broad screening context.
Range context
Lab reference interval
How to use the result
Save the result with date and symptoms from the same week.
Questions to ask directly
- •Is this typical chemo brain, or should we image to rule out CNS disease?
- •Which of my current medications might be contributing to the cognitive load?
- •Would cognitive rehabilitation or neuropsychological support help at this stage?
- •What is the expected recovery timeline for my specific treatment regimen?
Functional impact snapshot
- -Rate the specific cognitive domains affected: memory, word-finding, processing speed, multitasking.
- -Track whether symptoms are improving, stable, or worsening month over month.
- -Note impact on work, driving, and daily tasks - document for disability or accommodation requests.
Escalate instead of self-managing if
- •New focal neurological deficits suggesting brain metastasis or treatment-related leukoencephalopathy.
- •Rapidly progressive cognitive decline rather than the stable or slowly improving pattern of chemo brain.
- •Severe depression or suicidal ideation requiring immediate psychiatric attention.
Peer-reviewed references